شرکت گروه داروئی سبحان
@i_13643
What symbols does the trader recommend buying?
Purchase History
پیام های تریدر
Filter
شرکت گروه داروئی سبحان
Sobhan Pharmaceutical Group Company has sold 27.200 million shares on 14/07/07 and currently accounts for 58.009 % of Dolber's shares in its portfolio.
شرکت گروه داروئی سبحان
Sobhan Pharmaceutical Group Company in 1941.101 has bought Dushan's shares on 14/06/06 and currently accounts for 61.01 % of Doshan's shares in its portfolio.
شرکت گروه داروئی سبحان
Sobhan Pharmaceutical Group Company has bought 1167.223 million shares on 14/05/05 and currently accounts for 58.203 % of Dolbert's shares in its portfolio.
شرکت گروه داروئی سبحان
Sobhan Pharmaceutical Group Company bought 2985.954 million shares of Deano on 14/05/04 and currently accounts for 68.889 % of Deano's shares in its portfolio.
شرکت گروه داروئی سبحان
Sobhan Pharmaceutical Group Company purchased 0.300 million KBC shares on 14/03/14 and currently accounts for 47.449 % of KBC's shares in its portfolio.
شرکت گروه داروئی سبحان
Sobhan Pharmaceutical Group Company purchased 0.300 million KBC shares on 140/03/13 and currently accounts for 47.449 % of KBC shares in its portfolio.
شرکت گروه داروئی سبحان
Sobhan Pharmaceutical Group Company purchased 0.200 million KBC shares on 140/03/06 and currently accounts for 47.409 % of KBC's shares in its portfolio.
شرکت گروه داروئی سبحان
Sobhan Pharmaceutical Group Company purchased 0.100 million KBC shares on 140/02/31 and currently accounts for 47.382 % of KBC shares in its portfolio.
شرکت گروه داروئی سبحان
Sobhan Pharmaceutical Group Company purchased 0.100 million KBC shares on 140/02/30 and currently accounts for 47.368 % of KBC's shares in its joint portfolio.
شرکت گروه داروئی سبحان
Sobhan Pharmaceutical Group Company has sold 22,000 million shares on 14/02/29 and currently holds 1.011 percent of the broadcast in its joint portfolio.
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.